Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Active for Life Assisted Living Feasibility and Acceptability Study

26. august 2020 oppdatert av: Janet L. Larson, University of Michigan
This study examines the effects of a physical activity and behavioral program, called Active for Life, to promote increased physical activity and reduced sedentary behavior of older adults who live in assisted living. A sedentary lifestyle is very common in this population and if this program is successful it will be used to promote physical activity and improve the health of older adults in assisted living.

Studieoversikt

Status

Tilbaketrukket

Detaljert beskrivelse

Sedentary behavior (SB) is an emerging health risk, especially for older adults, as it is associated with chronic disease, loss of function, and increased disability and frailty. Older adults in assisted living (AL) are less active than their peers living independently. Recent evidence demonstrates there are substantial health benefits from light physical activity (LPA) and the newly published Physical Activity Guidelines for Americans recommends that older adults replace SB with LPA. An intervention to increase LPA and reduce SB has potential to reduce health risks, slow functional decline and frailty, and delay residents' needs for higher-level care such as a nursing home. We propose to test the feasibility and acceptability of a self-efficacy based intervention, "Active for Life," with the goal of increasing PA and decreasing SB of AL residents.

Active for Life is a 12 week intervention. Key components include (a) exercise with functional circuit training (FCT), walking, and stretching, (b) a behavioral component with a structured self-efficacy enhancing intervention that includes self-regulation strategies, and (c) education that addresses principles of exercise, the distinct health benefits of LPA, the negative consequences of too much sedentary time, and strategies for overcoming barriers to physical activity. It is important to test the feasibility and acceptability of the intervention for AL residents because this population will be more frail than previously tested populations. The intervention has been modified to be appropriate for AL residents based on guidance from AL experts and individual interviews conducted with AL residents. We will enroll 27 participants from approximately four AL facilities. Outcomes will be measured at baseline and at conclusion of the intervention. The primary outcomes are feasibility and acceptability of the intervention, but we will also examine preliminary evidence of outcome measures of objectively-measured sedentary behavior and physical activity, self-efficacy for exercise, value of physical activity, self-rated health, physical function, anxiety, depression, pain interference, and fatigue. This study is innovative because there are no well-established evidence-based interventions to promote PA in the AL setting and none that focus on increasing LPA and decreasing SB.

Studietype

Intervensjonell

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Michigan
      • Ann Arbor, Michigan, Forente stater, 48109
        • University of Michigan School of Nursing

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

55 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Residing in assisted living facility
  • Inactive (performing moderate level activities for less than 30 min./day, 5 day/week or not performing muscle strengthening activities twice/week) or a desire to increase physical activity
  • Score of at least 3 on the Mini-Cog cognitive screening

Exclusion Criteria:

  • Mobility issues that prevent participation in PA, such as if they rely on a wheelchair or motorized scooter (not excluded if they require an assistive device such as a cane or walker)
  • Hospitalization in the previous month
  • Skin on the thigh where ActivPAL monitor would be placed is not intact (has lesions, signs of infection, rash, or skin breakdown)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Active for Life
The Active Life intervention includes structured walking, functional circuit training, stretching and behavior/educational components.

Each intervention session will take place within the assisted living facility twice a week for 12 weeks.

Sessions will begin with 5-10 minutes of walking in the hallway. Participants will be encouraged to walk at their own pace and allowed to take breaks if needed.

Next, behavioral strategies based on the construct of self-efficacy from social cognitive theory and education about physical activity will be delivered. This component is scheduled between the walking and circuit training, lasts 15-20 minutes, and serves as a rest period.

Circuit training will focus on strength and balance. Approximately 8 exercise stations will be set up, and the exercises performed at each station will be changed approximately every 4 weeks. The circuit training will last ~30-40 minutes, with participants moving from one station to the next at their own pace and taking breaks in between.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Feasibility: Number of participants screened
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will calculate how many participants volunteered to be screened for participation in the study.
After completion of the 12 week intervention
Feasibility: Number of participants eligible
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will calculate how many participants met eligibility criteria for study participation.
After completion of the 12 week intervention
Feasibility: Numbers of participants ineligible by each eligibility criterion
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will summarize reasons that participants were ineligible for study participation by adding up the number of people who don't meet each specific eligibility criterion.
After completion of the 12 week intervention
Feasibility: Number of participants who enroll
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will calculate how many eligible participants decide to enroll in the study.
After completion of the 12 week intervention
Feasibility: Length of time for recruitment activities
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will calculate how much time is spent to recruit the study sample.
After completion of the 12 week intervention
Feasibility: Percentage of activity sessions attended by participants
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will calculate the percentage of activity sessions that participants attended.
After completion of the 12 week intervention
Feasibility: Participant retention rates
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will calculate retention rates of how many participants started and how many completed the study.
After completion of the 12 week intervention
Feasibility: Documentation of stated reasons for participant dropout
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will document stated reasons for dropout from the study as much as we are able.
After completion of the 12 week intervention
Feasibility: Injuries and adverse events
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will summarize any adverse events/injuries that occur during the study.
After completion of the 12 week intervention
Feasibility: Rates of missing or unusable data
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will summarize how much data are missing from baseline, mid-intervention, and post-intervention data collections.
After completion of the 12 week intervention
Feasibility: Time required to complete outcome measures
Tidsramme: After completion of the 12 week intervention
Several measures will be used to describe the feasibility of the intervention. We will keep record of how long each data collection session takes and calculate average length of data collection at both baseline and post-intervention.
After completion of the 12 week intervention
Acceptability: Exit interviews
Tidsramme: After completion of the 12 week intervention
Semi-structured exit interviews will ask questions related to acceptability of the intervention, such as how participants felt about the overall intervention and its specific components, whether the time commitment was reasonable, whether assisted living staff were supportive of their participation and goals, and any suggestions for future improvements.
After completion of the 12 week intervention
Acceptability: Final acceptability scale
Tidsramme: After completion of the 12 week intervention
This scale consists of 13 questions related to participants' overall satisfaction with the intervention and its components. Higher score indicates greater intervention acceptability.
After completion of the 12 week intervention

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Time spent in sedentary behavior and physical activity
Tidsramme: 7 days of data are gathered at baseline at after the 12 week intervention.
ActivPAL monitor will measure time spent sitting/lying, standing, and stepping for 7 consecutive days at each measurement.
7 days of data are gathered at baseline at after the 12 week intervention.
Self-efficacy for exercise
Tidsramme: Measured at baseline, three weeks, and after 12 week intervention.
Exercise self-efficacy- 9 items. Potential range of scores is 0 to 90. Higher score indicates higher self-efficacy for exercise.
Measured at baseline, three weeks, and after 12 week intervention.
Value of Physical Activity
Tidsramme: Measured at baseline and after 12 week intervention.
Single item asking "How important is physical activity in your life?" with a Likert response scale ranging from 1 to 5. Higher score will indicate greater importance of physical activity
Measured at baseline and after 12 week intervention.
Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health
Tidsramme: Measured at baseline and after 12 week intervention.
Physical, social, and mental health- 10 items. Scores are calculated as T-scores with a mean = 50 and standard deviation = 10. Low scores indicate low global health and higher scores indicate higher global health.
Measured at baseline and after 12 week intervention.
PROMIS Physical Functioning
Tidsramme: Measured at baseline and after 12 week intervention.
Physical function scale- measured with computer adaptive testing. Scores are calculated as T-scores with a mean = 50 and standard deviation = 10. Low scores indicate low physical function and higher scores indicate higher physical function.
Measured at baseline and after 12 week intervention.
PROMIS Anxiety
Tidsramme: Measured at baseline and after 12 week intervention.
General experience with anxious moods- measured with computer adaptive testing. Scores are calculated as T-scores with a mean = 50 and standard deviation = 10. Low scores indicate low anxiety and higher scores indicate higher anxiety.
Measured at baseline and after 12 week intervention.
PROMIS Depression
Tidsramme: Measured at baseline and after 12 week intervention.
General experience with depressed moods- measured with computer adaptive testing. Scores are calculated as T-scores with a mean = 50 and standard deviation = 10. Low scores indicate low depression and higher scores indicate higher depression.
Measured at baseline and after 12 week intervention.
PROMIS Fatigue
Tidsramme: Measured at baseline and after 12 week intervention.
General experience of fatigue- measured with computer adaptive testing. Scores are calculated as T-scores with a mean = 50 and standard deviation = 10. Low scores indicate low fatigue and higher scores indicate higher fatigue.
Measured at baseline and after 12 week intervention.
PROMIS Pain Interference
Tidsramme: Measured at baseline and after 12 week intervention.
Extent to which pain interferes with functioning- measured with computer adaptive testing. Scores are calculated as T-scores with a mean = 50 and standard deviation = 10. Low scores indicate low pain interference and higher scores indicate higher pain interference.
Measured at baseline and after 12 week intervention.
Positive and Negative Social Influences on PA in Older Adults
Tidsramme: Measured at baseline and after 12 week intervention.
Support from family and friends for being physically active. The questionnaire has 27 items (15 items describing positive social influence and 12 items describing negative social influence). The potential range of scores for positive social influence is 0 to 180 and the potential range of scores for negative social influence is 0 to 144.
Measured at baseline and after 12 week intervention.
Acceptability: Mid-point acceptability scale
Tidsramme: Measured at 6-weeks (mid-point of intervention)
This scale consists of 3 questions related to acceptability of intervention delivery. Higher score indicates greater intervention acceptability.
Measured at 6-weeks (mid-point of intervention)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Janet L Larson, PhD, RN, University of Michigan School of Nursing

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Forventet)

1. mai 2020

Primær fullføring (Forventet)

1. desember 2020

Studiet fullført (Forventet)

1. desember 2020

Datoer for studieregistrering

Først innsendt

30. april 2020

Først innsendt som oppfylte QC-kriteriene

8. mai 2020

Først lagt ut (Faktiske)

13. mai 2020

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

28. august 2020

Siste oppdatering sendt inn som oppfylte QC-kriteriene

26. august 2020

Sist bekreftet

1. august 2020

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

At this point the investigators have no plans to share IPD, but would consider a request to share deidentified data if it had the potential to advance science in the promotion of physical activity for older adults

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Stillesittende atferd

Kliniske studier på Active for Life: Assisted Living

3
Abonnere